FAG
CLB icon

Fortitude Advisory Group’s Core Laboratories CLB Stock Holding History

Fortitude Advisory Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125
Closed -$4K – 402
2022
Q1 		$4K Hold
125
– – ﹤0.01% 1198
2021
Q4 		$3K Buy
+125
New +$3.26K ﹤0.01% 1292

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fortitude Advisory Group's CLB Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 125 shares — an estimated $4K sold.

Fortitude Advisory Group first reported a position in CLB in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 125 Core Laboratories shares in Q2 2022, an estimated $4K.
  • Fortitude Advisory Group first reported a position in Core Laboratories in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Core Laboratories position peaked at $4K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.